The novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) is the cause of the COVID-19 pandemic [ 5 ]. SARS-Cov-2 demonstrates partial resemblance to SARS-CoV and MERS-CoV in phylogenetic analysis, clinical manifestations, and pathological findings [ 6 , 7]. Reports emerging from China have described ataxia as a neurological symptom of the SARS-CoV-2 infection [ 5 ]. Opsoclonus consists of back-to-back multidirectional conjugate saccades without an inter-saccadic interval [ 8 ]. Myoclonus is defined as a sudden, brief, “shock-like”, nonepileptic involuntary movement [ 9 ], which has been described as a symptom of SARS-CoV-2 infection [ 10 ]. Opsoclonus-Myoclonus-Ataxia syndrome (OMAS) associated COVID-19 infection has been reported recently [ 11 12 ].
【저자키워드】 SARS-CoV-2, Movement disorders, Post-infection, Opsoclonus-Myoclonus Ataxia Syndrome, 【초록키워드】 SARS-CoV, SARS-COV-2 infection, COVID-19 pandemic, Infection, Symptom, MERS-CoV, clinical manifestations, China, Phylogenetic analysis, COVID-19 infection, Myoclonus, Coronavirus-2, Opsoclonus, neurological, Ataxia, acute respiratory syndrome, novel coronavirus SARS-CoV-2, syndrome, report, defined, described, reported, pathological finding, saccade, the SARS-CoV-2, 【제목키워드】 Complication, Benign,